Skip to content
Science and Education

    • Genomic Tumor Profiling and Precision Oncology

    The Illumina Genomics Podcast

    Genomic Tumor Profiling and Precision Oncology

    Nov 20, 2019 | Episode 56 | 23 mins

    Understanding the mutational profile of a tumor can help to guide therapeutic options. Genomics has enabled the simultaneous analysis of multiple mutations across multiple genes, providing a comprehensive genomic profile of a given tumor. Listen to Dr. Rachel Sanborn of the Providence Cancer Institute explain how genomics technologies are empowering precision oncology.

    Audio Player
    00:00
    00:00
    00:00

    Related Episodes

    Developmental Biology Meets Immunotherapy
    Sep 03, 2020 | Episode 69 | 24 mins
    Although most developmental genes are silenced in adult somatic cells, some...
    Play Episode
    Comprehensive Genomic Tumor Profiling
    Dec 11, 2019 | Episode 57 | 20 mins
    NGS-based genomics assays can help characterize the genetic profile of a tu...
    Play Episode
    If Tumors Could Talk
    Oct 23, 2019 | Episode 54 | 22 mins
    Cancer is one of the leading causes of death around the world, and 38% peop...
    Play Episode
    View All Episodes
    Download or subscribe to our recurring podcasts.
    Apple Podcasts Google Podcasts Spotify RSS
    For Research Use Only

    Not for use in diagnostic procedures (except as specifically noted).

    Innovative technologies

    At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

    All trademarks are the property of Illumina, Inc. or their respective owners.
    For specific trademark information, see sapac.illumina.com/company/legal.html.

    © 2025 Illumina, Inc. All rights reserved.